| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/21/2010 | CN101011414B Improved lung-brain composition medicine |
| 07/21/2010 | CN101007011B Ginsenoside Rh2 self-emulsifying composition and its preparation method |
| 07/20/2010 | US7759526 Pharmaceutical compositions comprising cannabidiol derivatives |
| 07/20/2010 | US7759518 Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK |
| 07/20/2010 | US7759514 peptidomimetics such as (Z)-8-Amino-2-benzyl-3,7-dihydroxy-9-(4-hydroxy-phenyl)-non-4-enoic acid (1-carbamoyl-2-phenyl-ethyl)-amide, having improved selectivity to targets, improved bioavailability and lessened adverse side effects, used as analgesics |
| 07/20/2010 | US7759510 Platinum complexes and methods of use |
| 07/20/2010 | US7759502 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 07/20/2010 | US7759499 used for the treatment or prevention of HCV or amelioration the symptoms of hepatitis C infection, by modulating the interaction of an HCV polypeptide with HCV proteases |
| 07/20/2010 | US7759496 4-[6(2,2-dimethylpropanoyloxy)indan-1-ylmethyl]1H-imidazole, an alpha 2 adrenergic agonist, for the treatment of hypertension, glaucoma, headaches, diarrhea, ischemia, drug abuse and dependence, hypotension, shock, congestive heart failure, anxiety, as decongestants, analgesics or as sedatives |
| 07/20/2010 | US7759493 agonists of G-protein coupled receptor 40 (GPR40), useful for the treatment of non-insulin dependent diabetes, obesity and lipid disorders, such as diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia |
| 07/20/2010 | US7759488 Monoazole ligand platinum analogs |
| 07/20/2010 | US7759486 2,4,5-Trisubstituted pyrimidine compounds |
| 07/20/2010 | US7759478 viral genomic address messenger (VGAM); selectively inhibit translation of known host target genes, and are believed to represent a novel pervasive viral attack mechanism |
| 07/20/2010 | US7759472 Administering platelet derived growth factor antagonist and endothelial growth factor antagonist |
| 07/20/2010 | US7759399 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
| 07/20/2010 | US7759398 administering encapsulated cysteamine compound to treat hypercholesterolemia, non-insulin dependent diabetes; lowering uric acid levels |
| 07/20/2010 | US7759397 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 07/20/2010 | US7759396 Using alpha-ketoglutarate , mono- or divalent metal salts of alpha-ketoglutarate and/or ornithine of alpha-ketoglutarate; acting specifically on neoplastic cells with the simultaneous protective activity on the normal cells; synergic action with antineoplastic drugs and simultaneous protective activity |
| 07/20/2010 | US7759395 Di- and tri-hydroxy derivatives of eicosapentaenoic acid and docosahexaenoic acid coadministered with a cyclooxygenase-2 inhibitor; antiinflammatory agents |
| 07/20/2010 | US7759394 Diclofenac formulations and methods of use |
| 07/20/2010 | US7759393 Bio-derived 1,3-propanediol and its conjugate esters as natural and non irritating solvents for biomass-derived extracts, fragrance concentrates, and oils |
| 07/20/2010 | US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain |
| 07/20/2010 | US7759391 Pharmaceutical composition comprising thiacremonone for treating colon cancer |
| 07/20/2010 | US7759390 chemokine receptor 9(CCR9) antagonists such as, 5-Chloro-thiophene-2-sulfonic acid (4-cyano-2-methyl-phenyl)-amide, used for treating autimmune and inflammatory diseases, transplantat rejection and cancer |
| 07/20/2010 | US7759389 Chroman derivatives and uses thereof |
| 07/20/2010 | US7759388 Phenylalanine derivatives |
| 07/20/2010 | US7759387 such as (4-{2-[5-Carbamimidoyl-1-oxo-1,3-dihydro-isoindol-2-yl]-acetyl}-phenoxy)-acetic acid methyl ester, used for inhibiting the binding of fibrinogen to blood platelets, platelet aggregation and for the treatment of thrombotic diseases |
| 07/20/2010 | US7759386 Oral administering; drug with carrier and excipient |
| 07/20/2010 | US7759385 opioid receptor ligands such as {4-[3-(1H-indol-3-yl)-pyrrolidine-1-yl]-1-phenyl-cyclohexyl}-dimethylamine dihydrochloride salt, used as analgesics |
| 07/20/2010 | US7759384 Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment |
| 07/20/2010 | US7759383 Small molecule inhibitors of MDM2 and the uses thereof |
| 07/20/2010 | US7759382 such as N-{5-[1-(4-chloro-phenyl)-1-methyl-ethyl]-2H-pyrazol-3-yl}-2-[2-(3,5-difluoro-phenyl)-2-hydroxy-acetylamino]-propionamide, used for inhibiting beta-amyloid peptide release and/or biosynthesis, inhibiting gamma-secretase activity, prevention and treatment of Alzheimer's disease |
| 07/20/2010 | US7759380 Substituted pyrrolines as kinase inhibitors |
| 07/20/2010 | US7759379 Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 07/20/2010 | US7759378 Polyamino acid derivatives and use thereof in compositions for treating keratin fibers |
| 07/20/2010 | US7759377 2-{2-[2-hydroxy(3-methyl)butyrylamino]pentanoyl}amino-5-(1-methylethyl-4-(3-phenyl-1,2,4-oxadiazol-5-yl)thiazole; neurodegenerative diseases: senile dementia, Alzheimer's and Parkinson's diseases, Down's syndrome, amyloid angiopathy, cerebrovascular disorders, Pick's disease, post-traumatic dementias |
| 07/20/2010 | US7759376 diacylglycerol O-acyltransferase type 1(DGAT-1 ) inhibitors such as N-({3'-fluoro-4'-[(6-fluoro-1,3-benzothiazol-2-yl)amino]biphenyl-4-yl}carbonyl)-L-valine, used as dietetics |
| 07/20/2010 | US7759375 Epothilones C, D, E, and F, preparation and compositions |
| 07/20/2010 | US7759374 12,13-desoxyepothilones, used as anticarcinogenic agents |
| 07/20/2010 | US7759373 nitrogen-containing 5-membered heterocyclic compound |
| 07/20/2010 | US7759372 benzimidazole derivatives having antiviral activities, used optionally in combination with a polymerase inhibitor and/or a protease inhibitor |
| 07/20/2010 | US7759371 Anticancer, antitumor agents, using 2-amino-5-phenyl- (1,3,4)thiadiazoline compounds |
| 07/20/2010 | US7759370 Immunosuppressants for autoimmune diseases such as multiple sclerosis, transplant rejection; sphingosine-1-phosphate (S1P) receptor agonists; (S)-2-Amino-2-(5-(4-(2-(pentyloxy)ethoxy)-3-(trifluoromethyl)phenyl)-1,3,4-thiadiazol-2-yl)propyl dihydrogen phosphate for example |
| 07/20/2010 | US7759369 EP1 receptor antagonists; pain, inflammation, bone disorders, neurodegenerative disorders, renal disorders, immunological disorders; 6-(substituted benzyl)-2-pyridinecarboxylic acid, and corresponding amides, carboxysulfonamides, and tetrazoles, where benzyl is substituted with ether, sulfide, sulfone |
| 07/20/2010 | US7759368 Sustained release composition for oral administration of niacin |
| 07/20/2010 | US7759367 Pharmaceutical compositions and their uses |
| 07/20/2010 | US7759366 4-[4,4-Dimethyl-2,5-dioxo-3-(2-phenylaminobenzyl)imidazolidin-1-yl]-2-trifluoromethylbenzonitrile, used for treating syndrome X, diabetes, obesity, drug abuse and dependence, schizophrenia, Alzheimer's disease, polycystic ovary syndrome and as dietetics |
| 07/20/2010 | US7759365 chemokines receptor modulators such as 4-(2-ethyl-6-fluoro-3-{1-[3-(4-fluoro-phenylsulfanyl)-propyl]-piperidin-4-yl}-indol-1-yl)-benzoic acid ethyl ester, used for treating inflammatory diseases such as asthma and allergic diseases, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |
| 07/20/2010 | US7759364 Method for producing non-hydrated fexofenadine hydrochloride and a novel crystalline form obtained thereby |
| 07/20/2010 | US7759363 Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists |
| 07/20/2010 | US7759362 1-cyclopropyl-8-difluoromethoxyl-7-[(1S,6S)-2,8-diazabicyclo[4,3,0]nonane-8-yl]-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid hydrochloride, having potent antibacterial activity against broad-spectrum pathogenic bacteria, with favorable pharmacokinetics and very low toxicity |
| 07/20/2010 | US7759361 treating a cancer, autoimmune diseases and cardiovscular disorders comprising administering drugs such as Isobutyric acid 2-isobutyryloxymethyl-3-oxo-1-aza-bicyclo[2.2.2]oct-ylmethyl ester; antiproliferative agents |
| 07/20/2010 | US7759360 Administering cis-clomiphene and trans-clomiphene or analogs or pharmaceutically acceptable salts or solvates thereof wherein the ratio of trans-clomiphene and cis-clomiphene is greater than 1; treatment of hypogonadism |
| 07/20/2010 | US7759359 Uniform blood concentration; oral administering |
| 07/20/2010 | US7759358 duplex carbonate prodrug; opiates or opiate antagonists; esterification with Phosgene to form corresponding carbonate; increase in transdermal flux; Bis-Naltrexone carbonate; increased permeability or solubility though biotransformation by enzymes or hydrolysis into two drug molecules; transdermal patch |
| 07/20/2010 | US7759357 N-[4-3-chloro-phenyl)-pyrimidin-2-yl]-N-(4-trifluoromethyl-phenyl)-amine, having immunoglobulin E (IgE) synthesis inhibiting activity, used for treating rheumatoid arthritis |
| 07/20/2010 | US7759356 administering adenosine receptors antagonists, such as 2-amino-4-phenyl-indeno[1,2-d]pyrimidin-5-one, for the treatment of neurodegenerative diseases; Parkinson's Disease |
| 07/20/2010 | US7759355 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine |
| 07/20/2010 | US7759354 Bicyclic guanidine derivatives as asparyl protease inhibitors, compositions, and uses thereof |
| 07/20/2010 | US7759353 Substituted spiro iminopyrimidinones as aspartyl protease inhibitors, compositions, and methods of treatment |
| 07/20/2010 | US7759352 Substituted imidazole-4-carboxamides as cholecystokinin-1 receptor modulators |
| 07/20/2010 | US7759351 7-methoxy-2-methyl-N-[[(5S)-[3-[3-fluoro-4-(piperazin-1-yl)phenyl]-2-oxo-5-oxazolidinylmethyl]-3-quinolinecarboxamide, useful for the treatment of grampositive and some gramnegative bacterial infections, with a weak monoamine oxidase inhibitory activity |
| 07/20/2010 | US7759350 Pyrimidine carboxamides |
| 07/20/2010 | US7759349 helminthiasis in animals |
| 07/20/2010 | US7759348 Pyridazine derivatives and their use as therapeutic agents |
| 07/20/2010 | US7759347 polo-like kinase inhibitors used as antiproliferative and antitumor agents |
| 07/20/2010 | US7759346 [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain |
| 07/20/2010 | US7759345 ecteinascidins used for treating lung, colon, kidney, prostate, ovarian, breast and pancreatic cancers, leukaemia or melanoma |
| 07/20/2010 | US7759344 Bis-aryl amide derivatives and methods of use |
| 07/20/2010 | US7759343 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 07/20/2010 | US7759342 such as 8-(2-Fluorophenylamino)-2-(4-methoxyphenylamino)-9-(trans-4-(methylamino)cyclohexyl)-9H-purine, used for for inhibiting neutrophil accumulation in bronchoalveolar lavage fluid |
| 07/20/2010 | US7759341 progesterone receptor modulator and is effective in contraception, hormone replacement therapy, and treating carcinomas and adenocarcinomas, dysfunctional bleeding, uterine leiomyomata, endometriosis, and polycystic ovary syndrome |
| 07/20/2010 | US7759340 Antibacterial agents |
| 07/20/2010 | US7759339 such as 1-Phenyl-4-(m-tolylsulfonyl)piperazine, used in the treatment of type-2 diabetes, osteoporosis, hypertension, ocular disorders, cognitive disorders, the metabolic syndrome and other metabolic disorders |
| 07/20/2010 | US7759338 Programmed cell death, autoimmunity, inflammation, hyperproliferation; easy formulation, shelf life |
| 07/20/2010 | US7759337 N-cyclopropyl-4-methyl-3-{1-[(2R)-2-methylpiperazin-1-yl]phthalazin-6-yl}benzamide, useful for the prophylaxis and treatment of protein kinase mediated diseases including rheumatoid arthritis, psoriasis and other inflammation disorders |
| 07/20/2010 | US7759336 chemokine receptor antagonists such as N-(4-azepan-1-ylpyrimidin-2-yl)ethane-1,2-diamine, used for the treatment and prevention of inflammatory diseases, allergic diseases, acquired immunodeficiency syndrome infection with human immunodeficiency virus |
| 07/20/2010 | US7759335 Cardiometabolic disorders like obesity, diabetes, hypertension and dyslipidemias, 3, 4-diarylpyrazole derivatives; highly selective; limited or no CNS adverse side effects, including mood disorders |
| 07/20/2010 | US7759334 Soluble forms of amoxicillin and treatment of animals |
| 07/20/2010 | US7759333 pentaazacycle manganese complexes, as mimetics for oxidoreductase enzymes,used for the treatment of age-related macular degeneration, diabetic retinopathy and edema; vision defects |
| 07/20/2010 | US7759332 liver, lung, skin, breast, brain glioma, colon and rectum, stomach, head and neck, leukemia, malignant lymphoma, sarcoma, malignant melanoma, myeloma, and metastasis cancers |
| 07/20/2010 | US7759331 Pyridine-containing macroheterococylic compounds as kinase inhibitors |
| 07/20/2010 | US7759330 21-substituted progesterone derivatives as new antiprogestational agents |
| 07/20/2010 | US7759329 Method of treating human preeclampsia employing resibufagenin |
| 07/20/2010 | US7759328 Formeratol and budesonide for treatment of respiratory system disorders such as chronc obstructive pulmonary disease |
| 07/20/2010 | US7759327 Sanitizing agent having low concentrations of zinc acetate, lactate and oxide; chlorhexidine gluconate; panthenol; and silicone emulsion containing octanediol, glycerol octyl ether, and farnesol; optionally contains a quaternary ammonium compound; inhibit infectious disease transmission, nonirritating |
| 07/20/2010 | US7759326 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus |
| 07/20/2010 | US7759325 Phosphatidylcholine, phosphatidylinositol, phosphatidylethanolamine, phosphatidylserine and shingomyeline esterified by docosahexaensic acid or eicosapentaenoic acid |
| 07/20/2010 | US7759324 Antiadhesive carbohydrates |
| 07/20/2010 | US7759323 Highly purified antiendotoxin compound |
| 07/20/2010 | US7759322 Method of treating dry eye disease with purinergic receptor agonists |
| 07/20/2010 | US7759321 Administering a side-effect-avoiding dosage of a 1-alkoxyadenosine, excluding 2-methoxyadenosin; treating neuropathic pain and pain caused associated with inflammation or tissue damage |
| 07/20/2010 | US7759320 Compositions and methods for inhibiting expression of a gene from the Ebola |
| 07/20/2010 | US7759319 Oligomeric compounds and compositions for use in modulation of pri-mirnas |
| 07/20/2010 | US7759317 Analgesic and anti-inflammatory compositions and methods with flavonoid glycoside-type compounds |
| 07/20/2010 | US7759313 Induction method for cell differentiation |
| 07/20/2010 | US7759307 Compositions for protection against superficial vasodilator flush syndrome, and methods of use |
| 07/20/2010 | US7759116 Dengue viruses useful for vaccination against Flavivirus; Modified Vaccinia Virus Ankara (MVA); stable, can easily be produced |
| 07/20/2010 | US7759078 Diagnosis and treatment of cancer |
| 07/20/2010 | US7759070 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates |